oAFD®—Optical Atrial Fibrillation Detector
Loading...
Author
Genzoni, Elsa
Braun, Fabian
Van Zaen, Jérôme
Lemay, Mathieu
Vesin, Jean-Marc
Pruvot, Etienne
DOI
Abstract
Atrial Fibrillation (AF) is predicted to affect 17.9 million of people by 2060 in Europe. Its early detection is essential as AF is associated with high comorbidities and an increased mortality. Because of their limited recording duration existing solutions – such as ambulatory electrocardiogram (ECG) – do not allow to detect AF in its early stage in large populations. Moreover, 21-50% of patients suffering from AF are asymptomatic, which makes event-triggered-measurement devices unable to detect this arrhythmia. Recent advances in photoplethysmography technology give promise to detect AF in large populations with conveniently small wearable devices at low cost.
Publication Reference
CSEM Scientific and Technical Report 2019, p. 98
Year
2019